联环药业关于拟签订重大合同暨关联交易事项的公告
Filed with SSE ·
On 6ix: 6ix.com/news/news-26
6ix hasn’t read this filing yet.
Jiangsu Lianhuan Pharmaceutical Co., Ltd. on 6ix
Earlier from Jiangsu Lianhuan Pharmaceutical
- Announcement on Completion of Change in the Equity Structure of Indirect Shareholders
- Announcement on Active Pharmaceutical Ingredient Levonorgestrel Passing the World Health Organization Prequalification On-site Inspection
- Indicative Announcement on Change in Equity Structure of Controlling Shareholder
- Report for Q3 2025
- Announcement on Adjusting Members of Special Committees
Later from Jiangsu Lianhuan Pharmaceutical
- Announcement on Amending the Articles of Association, and Formulating and Revising Some Governance Systems
- Announcement on Adding Extraordinary Proposal to the 4th Extraordinary General Meeting in 2025
- Announcement on Holding Subsidiary Passing Generic Drug Consistency Evaluation
- Announcement on Convening the Q3 2025 Performance Briefing
- Announcement on Resolutions of the 4th Extraordinary General Meeting in 2025
Follow Jiangsu Lianhuan Pharmaceutical into a list and get an email when it puts out news.
Follow Jiangsu Lianhuan Pharmaceutical